Valneva SE (INRLF) Financials

INRLF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 427.9 million 339.7 million
Dec. 31, 2025 468.2 million 343.6 million
Sept. 30, 2025 526.0 million 349.4 million
June 30, 2025 557.1 million 337.3 million

INRLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -5.4 million ?
Dec. 31, 2025 -30.0 million ?
Sept. 30, 2025 -21.3 million ?
June 30, 2025 -4.8 million ?

INRLF Net Income

No data available :(

INRLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 121.1 million 188.7 million 28.1 million
Dec. 31, 2025 128.7 million 189.3 million 33.0 million
Sept. 30, 2025 168.4 million 127.8 million 33.0 million
June 30, 2025 190.1 million 144.2 million 33.6 million

INRLF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 197.2 million
Dec. 31, 2025 203.6 million
Sept. 30, 2025 180.6 million
June 30, 2025 181.4 million

INRLF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 284126 17.5 million 17.4 million -
Dec. 31, 2025 1.3 million 30.0 million 19.4 million 10.3 million
Sept. 30, 2025 783917 32.0 million 22.1 million 9.7 million
June 30, 2025 1.5 million 20.6 million 23.6 million 11.7 million

INRLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 35.5 million 30.1 million
Dec. 31, 2025 56.0 million 42.3 million
Sept. 30, 2025 34.5 million 28.1 million
June 30, 2025 57.0 million 28.4 million

INRLF

Price: $2.58

52 week price:
2.46
6.28

Earnings Per Share: -0.93 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 519.6 million

Links: